LeMaitre Q1 2026 Financial Results
LeMaitre Vascular, a US-based vascular device and implant company, announced robust Q1 2026 financial results featuring an 11% increase in sales to $66.6 million, a 42% rise in EPS to $0.68, and a gross margin improvement to 72.7%. The company cited growth across all major product lines and geographical regions, supported by higher prices and manuf…